DMEPOS Relief Act of 2025
- Sponsor
- Rep. Miller-Meeks, Mariannette [R-IA-1]
- Committees
- Ways and Means Committee (primary)
- Last action
- Mar 10, 2025
Bottom line
This bill temporarily maintains higher Medicare payment rates for durable medical equipment in non-competitive bidding areas, offering financial stability to suppliers but potentially increasing Medicare expenditures.
What it actually does
This bill directs the Secretary of Health and Human Services to extend current Medicare payment rates for certain durable medical equipment (DME) in non-competitive bidding areas by preventing a scheduled reduction. Specifically, it prolongs a transition rule that blends competitive bidding rates with historical rates for these items through December 31, 2025, and delays the full implementation of lower competitive bidding rates until January 1, 2026. This aims to provide financial relief to DME suppliers.
Proponents argue
Supporters argue that extending the current payment rates is crucial for ensuring the financial viability of DME suppliers, especially those in non-rural areas, who face rising operational costs. They contend that without this relief, many suppliers would struggle to provide essential equipment to Medicare beneficiaries, potentially leading to access issues for patients relying on critical medical devices.
Opponents contend
Critics might argue that delaying the implementation of competitive bidding rates undermines efforts to control Medicare spending and ensure taxpayer dollars are used efficiently. They could contend that competitive bidding is designed to drive down costs and that extending higher rates unnecessarily burdens the Medicare program, potentially leading to higher premiums or reduced benefits elsewhere.
The bill is very short and straightforward, allowing for quick comprehension by any interested reader.
Section 2(a)
Extension of Blended Payment Rates for DMEPOS in Non-Rural Areas
This provision directs the Secretary of Health and Human Services to continue applying a specific transition rule (42 CFR 414.210(g)(9)(v)) for Medicare payment of durable medical equipment in areas that are not rural or noncontiguous. This rule, which blends competitive bidding program rates with historical payment rates, will now apply through December 31, 2025, preventing a scheduled reduction to fully competitive bidding rates.
Supporters argue
Supporters argue this extension is vital for the financial stability of DME suppliers, particularly smaller businesses, preventing potential closures or service reductions that could jeopardize patient access to essential medical equipment. They contend that the current blended rates are more reflective of actual costs.
Critics contend
Critics might argue that this provision delays necessary cost-saving measures within Medicare. They could contend that competitive bidding was designed to achieve efficiencies and that extending higher rates represents an unnecessary expenditure of taxpayer funds, potentially leading to higher program costs.
Tradeoffs
The provision balances the financial viability of DME suppliers and patient access to equipment against the Medicare program's goal of cost containment through competitive bidding.
Section 2(b)
Postponement of Full Competitive Bidding Rates
This section prohibits the Secretary of Health and Human Services from implementing another specific regulation (42 CFR 414.210(g)(9)(vi)), which would fully apply competitive bidding program rates to DMEPOS items in non-competitive bidding areas, until January 1, 2026. This effectively extends the current, more favorable payment methodology for an additional period.
The bill's core mechanism relies on extending or delaying specific sections of the Code of Federal Regulations (42 CFR 414.210(g)(9)(v) and (vi)) which define Medicare payment methodologies for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS).
Section 2(a) and 2(b)
Why it matters:This is standard legislative practice for bills that modify existing regulatory frameworks, rather than an attempt to be evasive. It assumes a technical audience familiar with the regulations.
Case for: Referencing specific regulations ensures precision in legislative intent, directly targeting the exact policy mechanism to be adjusted without needing to rewrite complex regulatory text within the bill itself.
Case against: For the general public, this method makes the bill's actual impact opaque, requiring specialized knowledge or additional research to fully grasp its consequences.
Estimated impact: The impact is a temporary maintenance of higher Medicare reimbursement rates for DMEPOS items in non-competitive bidding areas, affecting the financial health of suppliers and Medicare expenditures.